InsiderTrades

Form 4 for AMGN Amgen

Accepted 2024-05-09 00:00:00 ET · period of report 2024-05-07 · accession 0001127602-24-014856 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2024-05-09 2024-05-07 AMGN Khosla Rachna SVP, Business Development A - Grant $0.00 +532 8,559 +7% $0
D 2024-05-09 2024-05-07 AMGN Khosla Rachna SVP, Business Development A - Grant $300.30 +3,461 3,461 New +$1.04M

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2024-05-07 A A 532 $0.00 8,559 D — — (F1) The Restricted Stock Units (RSUs) were granted pursuant to the Amgen Inc. 2009 Amended and Restated Equity Incentive Plan and vest in three annual installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively. (F3) These shares include 131 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. (F2) These shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 128 RSUs which will vest on 4/30/2025; 784 RSUs which will vest in installments of 386 on 11/5/2024 and 398 on 11/5/2025; 407 RSUs which will vest in installments of 200 on 5/2/2025, and 207 on 5/2/2026; 593 RSUs which will vest in in installments of 195 on 5/2/2025, 196 on 5/2/2026 and 202 on 5/2/2027; and 532 RSUs which will vest in installments of 175 on 5/7/2026, 176 on 5/7/2027, and 181 on 5/7/2028. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis.
2 Derivative Nqso (Right to Buy) 2024-05-07 A A 3,461 $300.30 3,461 D $300.30 · 2026-05-07 to 2034-05-07 3,461 Common Stock (F4) These non-qualified stock options are exercisable in three installments of 33%, 33% and 34% on 5/7/2026, 5/7/2027 and 5/7/2028, respectively.